Shandong Bailong Chuangyuan Bio-Tech Balance Sheet Health
Financial Health criteria checks 6/6
Shandong Bailong Chuangyuan Bio-Tech has a total shareholder equity of CN¥1.5B and total debt of CN¥52.4M, which brings its debt-to-equity ratio to 3.6%. Its total assets and total liabilities are CN¥1.7B and CN¥198.4M respectively. Shandong Bailong Chuangyuan Bio-Tech's EBIT is CN¥224.7M making its interest coverage ratio -45.2. It has cash and short-term investments of CN¥493.8M.
Key information
3.6%
Debt to equity ratio
CN¥52.43m
Debt
| Interest coverage ratio | -45.2x |
| Cash | CN¥493.78m |
| Equity | CN¥1.46b |
| Total liabilities | CN¥198.44m |
| Total assets | CN¥1.65b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 605016's short term assets (CN¥850.5M) exceed its short term liabilities (CN¥192.7M).
Long Term Liabilities: 605016's short term assets (CN¥850.5M) exceed its long term liabilities (CN¥5.7M).
Debt to Equity History and Analysis
Debt Level: 605016 has more cash than its total debt.
Reducing Debt: 605016's debt to equity ratio has reduced from 11.1% to 3.6% over the past 5 years.
Debt Coverage: 605016's debt is well covered by operating cash flow (355.8%).
Interest Coverage: 605016 earns more interest than it pays, so coverage of interest payments is not a concern.